Crossmark

Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

Crossref DOI link: https://doi.org/10.1016/j.endien.2024.01.007

Published Print: 2024-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mauricio, Didac

Escalada, Javier

Pérez, Antonio

Romero-Gómez, Manuel

Cusi, Kenneth

Younoussi, Zobair M.

Lazarus, Jeffrey V.
License Information

Text and Data Mining valid from 2024-04-01

Text and Data Mining valid from 2024-04-01
More Information

This article is maintained by: Elsevier

Article Title: Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2024.01.007

Content Type: article

Copyright: © 2024 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below